Literature DB >> 19352464

Accomplishments in 2007 in the adjuvant treatment of colorectal cancer.

Aimery de Gramont1, Daniel G Haller.   

Abstract

Overview of the Disease IncidencePrognosisCurrent General Standards and Regional Variations Colon Cancer Stage IIIStage IIRectal CancerAccomplishments (or Lack of Accomplishments) During the Year TherapyMethodologyPsycho-oncologyBASIC SCIENCE: BiomarkersWhat Needs To Be Done Controversies and DisagreementsFuture Directions Comments on ResearchObstacles to Progress.

Entities:  

Year:  2008        PMID： 19352464      PMCID： PMC2664907     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


  9 in total

1.  ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

Authors:  Gershon Y Locker; Stanley Hamilton; Jules Harris; John M Jessup; Nancy Kemeny; John S Macdonald; Mark R Somerfield; Daniel F Hayes; Robert C Bast
Journal:  J Clin Oncol       Date:  2006-10-23       Impact factor: 44.544

Review 2.  Lymph node evaluation and survival after curative resection of colon cancer: systematic review.

Authors:  George J Chang; Miguel A Rodriguez-Bigas; John M Skibber; Virginia A Moyer
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

3.  Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Authors:  J Philip Kuebler; H Samuel Wieand; Michael J O'Connell; Roy E Smith; Linda H Colangelo; Greg Yothers; Nicholas J Petrelli; Michael P Findlay; Thomas E Seay; James N Atkins; John L Zapas; J Wendall Goodwin; Louis Fehrenbacher; Ramesh K Ramanathan; Barbara A Conley; Patrick J Flynn; Gamini Soori; Lauren K Colman; Edward A Levine; Keith S Lanier; Norman Wolmark
Journal:  J Clin Oncol       Date:  2007-04-30       Impact factor: 44.544

4.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

5.  Current status of adjuvant therapy for colon cancer.

Authors:  Thierry André; Pauline Afchain; Alain Barrier; Pierre Blanchard; Annette K Larsen; Christophe Tournigand; Christophe Louvet; Aimery de Gramont
Journal:  Gastrointest Cancer Res       Date:  2007-05

6.  Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.

Authors:  John L Marshall; Daniel G Haller; Aimery de Gramont; Howard S Hochster; Heinz-Josef Lenz; Jaffer A Ajani; Richard M Goldberg
Journal:  Gastrointest Cancer Res       Date:  2007-07

7.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Authors:  Jessica B O'Connell; Melinda A Maggard; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2004-10-06       Impact factor: 13.506

8.  Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

Authors:  Thierry André; Emmanuel Quinaux; Christophe Louvet; Philippe Colin; Erik Gamelin; Olivier Bouche; Emmanuel Achille; Pascal Piedbois; Nicole Tubiana-Mathieu; Arnaud Boutan-Laroze; Michel Flesch; Gérard Lledo; Yves Raoul; Isabelle Debrix; Marc Buyse; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

9.  Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Authors:  Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544
  9 in total
  1 in total

1.  Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.

Authors:  M Kornmann; L Staib; T Wiegel; E-D Kreuser; M Kron; W Baumann; D Henne-Bruns; K-H Link
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.